GARUX
Price
$11.41
Change
+$0.04 (+0.35%)
Updated
Jun 2 closing price
Net Assets
6.15B
SMSAX
Price
$10.69
Change
+$0.06 (+0.56%)
Updated
Jun 2 closing price
Net Assets
240.97M
Interact to see
Advertisement

GARUX vs SMSAX

Header iconGARUX vs SMSAX Comparison
Open Charts GARUX vs SMSAXBanner chart's image
GARUX vs SMSAX Comparison Chart in %
View a ticker or compare two or three
VS
GARUX vs. SMSAX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GARUX is a StrongBuy and SMSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GARUX has more cash in the bank: 6.15B vs. SMSAX (241M). SMSAX pays higher dividends than GARUX: SMSAX (4.75) vs GARUX (0.46). GARUX was incepted earlier than SMSAX: GARUX (11 years) vs SMSAX (16 years). SMSAX (2.93) is less costly to investors than GARUX (0.79). SMSAX is a more actively managed with annual turnover of: 358.00 vs. GARUX (134.00). SMSAX has a lower initial minimum investment than GARUX: SMSAX (100000) vs GARUX (5000000). SMSAX annual gain was more profitable for investors over the last year : 16.21 vs. GARUX (12.91). SMSAX return over 5 years is better than : 19.01 vs. GARUX (17.75).
GARUXSMSAXGARUX / SMSAX
Total Expense Ratio0.732.1833%
Annual Report Gross Expense Ratio0.792.9327%
Fund Existence11 years16 years-
Gain YTD6.3616.72795%
Front LoadN/AN/A-
Min. Initial Investment50000001000005,000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.15B241M2,551%
Annual Yield % from dividends0.464.7510%
Returns for 1 year12.9116.2180%
Returns for 3 years29.4833.3788%
Returns for 5 years17.7519.0193%
Returns for 10 years41.9638.98108%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCINX13.59N/A
N/A
VALIC Company I International Growth
FSMEX43.98N/A
N/A
Fidelity Select Medical Tech and Devcs
ISFIX20.51N/A
N/A
VY® Columbia Contrarian Core I
FRBRX189.71N/A
N/A
Franklin Biotechnology Discovery R6
JHEQX34.71N/A
N/A
JPMorgan Hedged Equity I